Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
约翰·霍普金斯大学艾滋病流行病学和预防科学培训计划
基本信息
- 批准号:10401811
- 负责人:
- 金额:$ 42.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
7. PROJECT SUMMARY
This proposal is a renewal application for a second 5-year National Research Service Award Institutional
Research Grant to support a training program in HIV Epidemiology and Prevention Sciences at the Johns
Hopkins Bloomberg School of Public Health (BSPH) and the Johns Hopkins School of Medicine (SOM),
entitled the “Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program.” The
program is led by Director Chris Beyrer MD, MPH, and Deputy Director Shruti Mehta PhD, MPH. We are
requesting support for 3 pre- and 4 post-doctoral trainees, which represents an increase of 2 post-doctoral
trainees from our prior funding period. The program mission is to train pre-doctoral students and post-doctoral
fellows to become leaders at the forefront of highest priority HIV research with advanced competencies and
state-of-the-art skills in three training tracks: HIV Epidemiology and Implementation Science Methods
including training in (1) Populations and Study Designs, including identification, recruitment and retention; (2)
Measurement issues in HIV populations, including innovative methods for surveillance, recruitment, estimation
of HIV prevalence and incidence, (3) Inference techniques, including modern analytical methods for causal
inference and mathematical modeling; and (4) Synthesis and Implementation of research findings to public
health practice; HIV Clinical and Laboratory Sciences including training in (1) the epidemiology, prevention
and treatment of major co- infections with HIV including hepatitis C virus (HCV) infection and tuberculosis; (2)
epidemiology and pathogenesis of HIV and age-associated co-morbidities; and (3) Measurement and use of
genetic, virologic and immunologic factors that can inform our knowledge of the pathogenesis and transmission
of HIV; HIV Prevention Sciences including how to prevent and reduce the prevalence and incidence of HIV
through training in (1) Design and Analysis of HIV biomedical, behavioral and combination prevention trials,
including treatment as prevention research (TasP), oral and topical PrEP trials, HIV vaccine trials and passive
immune-therapy trials, and (2) Community-based population-level approaches to HIV prevention and control
beyond individual behavior change. Our program, which is fully integrated through the JHU Center for AIDS
Research (CFAR) has resulted in a rich and interactive environment for trainees working in HIV augmented by
the exceptionally innovative, productive and collaborative HIV research conducted by epidemiological, clinical,
prevention and implementation scientists throughout Johns Hopkins BSPH, and SOM.
7. 项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shruti H Mehta其他文献
M132 - Depression Profiles and Hepatitis C Treatment Outcomes Among Persons who Inject Drugs: The Hero Study
M132 - 注射毒品者的抑郁特征与丙型肝炎治疗结果:英雄研究
- DOI:
10.1016/j.drugalcdep.2023.110412 - 发表时间:
2024-07-01 - 期刊:
- 影响因子:3.600
- 作者:
Snehal Lopes;Irene Pericot-Valverde;Judith Feinberg;Shadi Nahvi;Paula Lum;Lynn Taylor;Judith Tsui;Shruti H Mehta;Brianna Norton;Arthur Kim;Julia Arnsten;James Thrasher;Kimberly Page;Moonseong Heo;Alain Litwin - 通讯作者:
Alain Litwin
S72 - The Association of Self-Report Adherence to Hepatitis C (HCV) Direct-Acting Antiviral (DAA) Therapy With Measured Adherence and Sustained Virologic Response Among People Who Inject Drugs (PWID) Receiving Opioid Agonist Therapy
S72 - 注射毒品者(PWID)接受阿片类激动剂治疗期间,自我报告的丙型肝炎(HCV)直接作用抗病毒(DAA)治疗依从性与测量依从性和持续病毒学应答的关联
- DOI:
10.1016/j.drugalcdep.2023.110183 - 发表时间:
2024-07-01 - 期刊:
- 影响因子:3.600
- 作者:
Snehal Lopes;Irene Pericot-Valverde;Julia Arnsten;Paula Lum;Lynn Taylor;Shruti H Mehta;Judith Tsui;Judith Feinberg;Arthur Kim;Brianna Norton;Kimberly Page;Moonseong Heo;Alain Litwin - 通讯作者:
Alain Litwin
EXPLORATION OF HIV RISK BEHAVIORS AND ATTITUDES TOWARDS PREP AMONG PEOPLE WHO INJECT DRUGS BY GENDER AND SEXUAL ORIENTATION
按性别和性取向对注射毒品者中探索艾滋病病毒风险行为及对暴露前预防(PREP)态度的研究
- DOI:
10.1016/j.drugalcdep.2023.110036 - 发表时间:
2024-07-01 - 期刊:
- 影响因子:3.600
- 作者:
Elenore Bhatraju;Judith Tsui;Andrea C. Radick;Moonseong Heo;Laksika Sivaraj;Shruti H Mehta;Paula Lum;Lynn Taylor;Judith Feinberg;Arthur Kim;Brianna Norton;Irene Pericot-Valverde;Kimberly Page;Alain Litwin - 通讯作者:
Alain Litwin
Shruti H Mehta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shruti H Mehta', 18)}}的其他基金
Integrating HCV services into HIV programs for PWID in India
将 HCV 服务纳入印度针对注射吸毒者的艾滋病毒项目
- 批准号:
10651729 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
消除艾滋病毒感染者和未感染者注射吸毒者中的丙型肝炎病毒和相关肝脏疾病
- 批准号:
10319551 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
消除艾滋病毒感染者和未感染者注射吸毒者中的丙型肝炎病毒和相关肝脏疾病
- 批准号:
10543537 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Integrating HCV services into HIV programs for PWID in India
将 HCV 服务纳入印度针对注射吸毒者的艾滋病毒项目
- 批准号:
9974478 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Integrating HCV services into HIV programs for PWID in India
将 HCV 服务纳入印度针对注射吸毒者的艾滋病毒项目
- 批准号:
10210233 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Integrating HCV services into HIV programs for PWID in India
将 HCV 服务纳入印度针对注射吸毒者的艾滋病毒项目
- 批准号:
10433886 - 财政年份:2019
- 资助金额:
$ 42.47万 - 项目类别:
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
约翰·霍普金斯大学艾滋病流行病学和预防科学培训计划
- 批准号:
10617066 - 财政年份:2013
- 资助金额:
$ 42.47万 - 项目类别:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
印度钦奈注射吸毒者的艾滋病毒、丙型肝炎和肝病
- 批准号:
8535239 - 财政年份:2010
- 资助金额:
$ 42.47万 - 项目类别:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
印度金奈注射吸毒者的艾滋病毒、丙型肝炎和肝病
- 批准号:
8713968 - 财政年份:2010
- 资助金额:
$ 42.47万 - 项目类别:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
印度钦奈注射吸毒者的艾滋病毒、丙型肝炎和肝病
- 批准号:
8133094 - 财政年份:2010
- 资助金额:
$ 42.47万 - 项目类别:
相似国自然基金
基于分子-社会网络的成渝地区MSM人群HIV感染风险识别及协同管理机
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于人工智能算法构建HIV/HBV合并感染预后模型
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于潜变量增长混合模型的HIV/AIDS患者症状负担发展轨迹研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
HIV缺陷型储存库经抗病毒免疫影响结直
肠癌细胞恶性表型的作用机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
HIV-1与免疫应答致低病毒血症综合研究
- 批准号:2025JJ80674
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
新型工程化广谱中和抗体清除HIV-1潜伏
感染细胞的功能和机制
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
基于CRISPR-电化学传感联用的HIV快速检测技术研发及基层应用
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
非HIV阳性肺孢子菌肺炎患者的临床特征和预后危险因素分析:一项多中心回顾性队列研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
- 批准号:2025JJ80476
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于深度测序的HIV多联耐药检测技术开发及其临床应用研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
- 批准号:
10369859 - 财政年份:2021
- 资助金额:
$ 42.47万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10212958 - 财政年份:2020
- 资助金额:
$ 42.47万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10405074 - 财政年份:2020
- 资助金额:
$ 42.47万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10640251 - 财政年份:2020
- 资助金额:
$ 42.47万 - 项目类别:
Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)
HIV 分子流行病学预防 (HIV-ME) 的风险、益处和利益相关者观点
- 批准号:
10082384 - 财政年份:2020
- 资助金额:
$ 42.47万 - 项目类别:
HIV Epidemiology and Prevention Programme
艾滋病毒流行病学和预防计划
- 批准号:
MC_UU_00027/3 - 财政年份:2018
- 资助金额:
$ 42.47万 - 项目类别:
Intramural
The Transnational Cohort: global HIV epidemiology and prevention research for transwomen.
跨国队列:跨性别女性的全球艾滋病毒流行病学和预防研究。
- 批准号:
9065249 - 财政年份:2015
- 资助金额:
$ 42.47万 - 项目类别:
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
约翰·霍普金斯大学艾滋病流行病学和预防科学培训计划
- 批准号:
10617066 - 财政年份:2013
- 资助金额:
$ 42.47万 - 项目类别:
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
约翰·霍普金斯大学艾滋病流行病学和预防科学培训计划
- 批准号:
9897479 - 财政年份:2013
- 资助金额:
$ 42.47万 - 项目类别:
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
约翰·霍普金斯大学艾滋病流行病学和预防科学培训计划
- 批准号:
8879021 - 财政年份:2013
- 资助金额:
$ 42.47万 - 项目类别: